Chapter One:
Executive Summary
- Scope and
Methodology
- Markets -
Pharmacists Impact
- The Prescribing
Pharmacist
- Main Drivers For
Increased Pharmacist Prescription Authority
- Issues and Trends
Shaping the Industry
- Methodology
Chapter Two:
Introduction
- History and
Description
- Role of the US
Pharmacist
- Role in
Distributing Controlled Substances
- Variations in
Prescribing Authority
- Pharmacists
Statistics
- Overview
- Earnings and
Distribution by Employment Type
- State
Concentrations
- Training and
Certification
Chapter Three:
Issues and Trends Shaping the Industry
- US Healthcare
Expenditures
- Rising Healthcare
Costs and Health Insurance Trends
- Pharmaceutical
Trends
- Units Sales and
Revenues of Top Branded Drugs
- Population Growth
and the Existing Need
- Medication Safety
- Medication Errors
- Reducing Errors in
Hospitals
- Drug Interactions
- Interactions and
the Evolving Pharmaceutical Industry
- Prescribing Trends
of Select Federal Programs
- State Comparison
of Collaborative Practice
- Hospital Case
Studies and Collaborative Drug Therapy Management
- HCA Hospitals
- Barriers to
Collaborative Practice
- International
Trends
- England
- Scotland
- Wales
- Northern Ireland
- Canada
- Japan
- Australia
Chapter Four:
Pharmacist Impact on
Pharmaceutical Markets
- Overview
- The Pharmacist
Influence
- Influencing Drug
Choice
- Influencing Drug
Dosage, Administration, or Other Therapy Aspects
- Therapeutic Areas
Most Influenced
- chapter Five: The
Emerging Prescribing Pharmacist
- Differing Views on
Increasing Roles of the Pharmacist
- Physicians’ View
on Increasing Involvement in Prescribing
- Pharmacists’ View
on Increasing Involvement in Prescribing
- States Most Likely
to Implement Independent Prescribing
- Market Impact
APPENDIX:
Nationwide Boards of Pharmacy
table of exhibits
Chapter One:
Executive Summary
- Figure 1-1:
Declining Drug Purchases Not Influenced By Pharmacist 2006-2012
- Table 1-1:
Pharmacists Influence in Drug Selection and/or Therapy Aspect:
2006 and 2012
- Figure 1-2:
Pharmacists Influence in Drug Selection and/or Drug Aspect, 2006
and 2012
Chapter Two:
Introduction
- Table 2-1:
Examples of Controlled Substances by Schedule
- Table 2-2: Number
of Pharmacists in the Workforce 2004-2006
- Table 2-3: 2004
Median Annual Income Levels for U.S. Pharmacists
- Figure 2-1: 2004
Median Annual Income Levels for U.S. Pharmacists
- Table 2-4: 2005
Leading Employment Areas and Income Statistics for U.S.
Pharmacists
- Table 2-5: 2006
Leading Employment Areas and Income Statistics for U.S.
Pharmacists
- Figure 2-2: Number
of Pharmacists (2005/2006) in Leading Employment Areas in the U.S.
- Figure 2-3: Mean
Level of Income (2005/2006) for Leading Employment Areas in the
U.S.
- Table 2-6:
Pharmacist Concentrations for the Top Five States in 2006
- Figure 2-4:
Pharmacist Concentrations for the Top Five States in 2006
- Table 2-7:
Pharmacist Concentrations for the Top Five U.S. Metropolitan Areas
in 2006
- Figure 2-5:
Pharmacist Concentrations for the Top Five U.S. Metropolitan Areas
in 2006
- Table 2-8: Number
of Pharmacists Employed in all U.S. States, District of Columbia
and U.S. Territories in 2006
- Figure 2-6: Top 20
States with the Most Pharmacists in the Workforce in 2006 Table
2-9: Accredited Pharmacy Education Centers by State
Chapter ThreE:
Issues and Trends Shaping the Industry
- Table 3-1: U.S.
Prescription and Total Healthcare Expenditures 1995, 2000, and
2005
- Figure 3-1: U.S.
Prescription and Total Healthcare Expenditures 1995, 2000, and
2005
- Table 3-2: Percent
Insured in the U.S. by Income Level
- Figure 3-2:
Percent Insured in the U.S. by Income Level
- Table 3-3: Health
Insurance Trends in the United States 2003-2005
- Figure 3-3: Number
Insured in the United States 2003-2005
- Table 3-4: Retail
Pharmaceutical Sales in the U.S. 1995, 2000 and 2004
- Figure 3-4:
Distribution of Retail Pharmaceutical Sales from 1995, 2000 and
2004
- Table 3-5: Top Ten
Prescribed Branded Drugs by Estimated Unit Sales in the U.S.
- Table 3-5: Top Ten
Prescribed Branded Drugs by Estimated Unit Sales in the U.S.
- Table 3-6: Top Ten
Prescribed Branded Drugs and U.S. Revenues
- Figure 3-6: Top
Ten Prescribed Branded Drugs and U.S. Revenues
- Table 3-7: Top Ten
Prescribed Branded Drugs and Worldwide Revenues
- Figure 3-7: Top
Ten Prescribed Branded Drugs and Worldwide Revenues
- Table 3-8: United
States Population and Age Statistics
- Figure 3-8: United
States Population and Age Statistics
- Table 3-9:
Increase in the Oldest U.S. Population
- Figure 3-9:
Increase in the Oldest U.S. Population
- Figure 3-10:
Distribution of Fatal Prescribing Errors
- Table 3-10: Select
2007 Safety Alerts for Drugs and Therapeutic Biological Products
- Table 3-11: Drug
Interaction Information
- Figure 3-11:
Timeline of U.S. Pharmacy Collaboration
- Table 3-12: States
That Allow Collaboration Agreements between Pharmacist and
Physician
- Table 3-13:
Pharmacists per Employment Category in Japan (2004)
Chapter Four:
Pharmacist Impact on Pharmaceutical Markets
- Table 4-1:
Pharmacists Influence in Drug Selection and/or Drug Therapy
Aspect, 2006 and 2012
- Figure 4-1 :
Pharmacists Influence in Drug Selection and/or Therapy Aspect,
2006 and 2012
- Table 4-2:
Pharmacists Influence in the US Drug Market, Influencing Drug
Choice, 2006
- Figure 4-2:
Pharmacists Influence in the US Drug Market, Influencing Drug
Choice, 2006
- Figure 4-3: Drug
Markets Most Influenced by Pharmacists by Therapeutic Category,
2006
- Table 4-3:
Pharmacists Influence in the US Drug Market, Influencing Drug
Dosage, Administration, and Other Therapy Aspect, 2006
- Figure 4-3:
Pharmacists Influence in the US Drug Market, Influencing Drug
Dosage, Administration, and Other Therapy Aspect, 2006
chapter Five: The
Emerging Prescribing Pharmacist
- Table 5-1: States
Most Likely to Allow Prescription, Those to Follow, and States Not
Likely to Allow Independent Prescribing
|
